Document is current

Article History

Received: 5 June 2024

Accepted: 6 May 2025

First Online: 14 May 2025

Declarations

:

: This study was approved by the institutional review board of King Saud University and three hospitals involved in the study before this study could proceed (Ref: No: KSU-HE-22-588) (QCH-SRECO 34/2022) (EXT-Gynea-2022-002) (H-05-HS-065). All participants provided their written informed consent to participate voluntarily and reminded of their right to withdraw at any time without any penalty. They were assured that their responses would be kept confidential and only accessible to the members of the research team. To maintain confidentiality, participants were assigned codes to use instead of their names. Finally, all participants agreed to be recorded, and they were assured that all responses and transcripts would be securely destroyed. Lastly, COREQ guidelines, which are a unified set of criteria for reporting qualitative research, were applied [].

: Participants gave their informed written consent for their data to be coded for analysis, and for certain anonymous citations to be included in the publication, while respecting their confidentiality.

: The authors declare no competing interests.